FORENSIC TOXICOLOGY.NETOkorie Okorocha, J.D., M.S., M.S.Forensic Toxicology Expert Witness

EVIDENCE LIBRARY

1,1-Difluoroethane (DFE) Forensic Toxicology

By forensic toxicology working group members

Forensic guide to 1,1-difluoroethane (DFE): blood detection, headspace GC testing, volatile loss, postmortem specimens, impairment, and interpretation limits.

1,1-Difluoroethane (DFE), also called HFC-152a, is a volatile fluorinated hydrocarbon used as a propellant in some aerosolized air-duster products. In forensic toxicology, DFE presents an unusual combination of problems: effects can begin within seconds, blood concentrations can change rapidly, the compound can be lost during specimen handling, and a negative routine drug screen does not exclude exposure because many conventional toxicology panels are not designed to detect volatile inhalants.

This guide focuses on the evidentiary questions that matter most: what specimen was collected, how it was preserved, whether the analytical method could detect DFE, how quickly the compound may dissipate, and what a reported concentration can—and cannot—establish.

Quick answer: what does a positive DFE result mean?

A confirmed DFE finding supports exposure to 1,1-difluoroethane in the tested specimen. It does not, by itself, establish the exact dose inhaled, the number of inhalations, the precise time of use, the degree of impairment at an earlier event, or whether DFE independently caused a death. Those questions require the analytical result to be integrated with collection timing, specimen type, scene evidence, medical history, autopsy findings, co-intoxicants, and the limitations of the method.

Why DFE is different from many conventional drugs

DFE is a gas at ordinary environmental conditions and behaves very differently from drugs that remain stable in blood or urine for days. A 2021 review in the Journal of Analytical Toxicology described rapid pulmonary absorption, central nervous system depressant effects beginning within seconds, and effects that may be short-lived after isolated exposure. The same review emphasized that DFE concentrations dissipate rapidly and that the compound has been identified in both impaired-driving and postmortem investigations. Tiscione & Rohrig, 2021 (PubMed).

That rapid behavior creates a central forensic distinction: the duration of observable effects and the duration of analytical detectability are related but are not identical. A person may no longer display the most obvious acute effects by the time of examination, while DFE may still be analytically detectable if an appropriate specimen is collected and a sufficiently sensitive method is used.

How long can DFE be detected in blood?

There is no single universal detection window. Detectability depends on the intensity and duration of exposure, the elapsed time before collection, body composition and distribution, specimen handling, and—critically—the laboratory’s limit of detection or reporting limit.

A physiologically based pharmacokinetic modeling study published in 2020 concluded that DFE may remain detectable in blood for hours after an abuse episode, with predicted detection time changing substantially as the analytical threshold and exposure scenario changed. The authors specifically cautioned that detection time depends on body burden, analytical sensitivity, inhalation pattern, and physiological variability. Huet & Johanson, 2020 (PubMed).

Forensic interpretation should therefore avoid statements such as “DFE is gone after X hours” unless the statement is tied to a defined method, detection limit, exposure model, and specimen. For a broader discussion of this issue, see Detection Windows in Forensic Toxicology.

Which specimens are useful?

Blood

Blood is a primary specimen in both driving and death investigations because it can directly demonstrate DFE present in circulation at collection. However, interpretation requires attention to whether the sample is peripheral or central, the collection interval, tube type, storage conditions, and potential evaporative loss.

Central versus peripheral blood

In postmortem work, central and peripheral blood should not automatically be treated as interchangeable. A San Diego County Medical Examiner series reported DFE measurements in both central and peripheral blood and discussed the possible interpretive value of comparing the two. Vance, Swalwell & McIntyre, 2012 (PubMed). Any ratio, however, must be interpreted in the context of collection site, postmortem interval, redistribution, and case circumstances rather than used as a universal clock.

See also Central and Peripheral Blood and Postmortem Redistribution.

Vitreous, tissues, and alternative postmortem specimens

Published case literature has reported DFE in vitreous and tissues. The 2021 forensic review also noted that brain, lung, and tracheal air may be useful alternative specimens in selected postmortem investigations. These matrices can provide corroborating evidence, but concentrations from different tissues should not be converted or compared as though they represent the same biological compartment.

How is DFE analyzed?

Because DFE is volatile, forensic methods commonly rely on headspace gas chromatography coupled with flame-ionization detection or mass spectrometric detection. Headspace analysis allows volatile compounds to partition from the specimen into the gas phase above it before chromatographic separation.

A validated ethanol headspace GC method can, in some laboratories, also provide qualitative identification of DFE, but laboratories must demonstrate that their method is actually capable of detecting and distinguishing the compound under the conditions used. A method validated only for ethanol should not be assumed to be a comprehensive volatile screen. See Headspace Gas Chromatography in Forensic Toxicology and Method Validation in Forensic Toxicology.

Why specimen handling matters so much

Volatile compounds can be lost through evaporation and repeated opening of a specimen container. The evidentiary review should therefore identify the original collection tube, fill volume, cap integrity, storage temperature, transport conditions, number of prior analyses, aliquoting history, and whether the specimen was repeatedly opened or transferred.

For a DFE result, a good laboratory-record review asks whether the analytical aliquot was taken directly from the original container, whether headspace was minimized, whether the sample was refrigerated or frozen as appropriate, whether reanalysis occurred after a substantial delay, and whether the laboratory has stability data relevant to the tested matrix and storage conditions. See Specimen Storage and Stability in Forensic Toxicology.

Can a routine toxicology screen miss DFE?

Yes. Many routine drug-testing panels target drugs and metabolites by immunoassay, LC-MS/MS, GC-MS, or other methods that are not configured to capture a highly volatile propellant. A negative standard drug screen therefore does not necessarily answer whether DFE was present.

In the San Diego County series, DFE was identified during routine ethanol screening, illustrating why the analytical scope matters. The relevant question is not simply whether “toxicology was negative,” but which analytes and volatile compounds the laboratory method was capable of detecting and at what threshold.

DFE concentration and impairment

DFE can produce rapid central nervous system effects including confusion, impaired judgment, impaired motor coordination, lethargy, and loss of consciousness. The 2021 review reported that the most obvious effects may begin within seconds and may resolve quickly after isolated exposure. This makes retrospective impairment analysis difficult.

A measured blood concentration should not be treated like a per se alcohol threshold. Published DFE case concentrations span wide ranges, and the measured number depends heavily on collection timing, exposure pattern, body distribution, specimen handling, and analytical sensitivity. A concentration may support recent exposure, but translating it into an exact degree of impairment at an earlier moment is generally much less certain.

DFE in postmortem toxicology

Deaths involving DFE have been reported in forensic case series and case reports. The San Diego County Medical Examiner series described 17 cases with DFE detected in postmortem tissues and reported that DFE was cited in the cause of death in 13 of those cases. The authors also emphasized the value of routine screening because scene evidence such as discarded aerosol cans may be absent or overlooked. Vance et al., 2012.

Cause-of-death analysis should still remain case-specific. A positive DFE result should be evaluated alongside autopsy findings, scene circumstances, position of the body, evidence of asphyxia or trauma, co-intoxicants, underlying cardiac disease, resuscitation, and alternative mechanisms of death. For the broader framework, see Postmortem Toxicology.

Key records to request in a DFE case

  • Original toxicology report and any amended reports.
  • Specimen inventory, collection times, collection sites, tube types, preservatives, and storage history.
  • Headspace GC chromatograms and, when applicable, mass spectra.
  • Calibration, calibrator, blank, control, and sequence records from the analytical batch.
  • Method validation or verification documents showing DFE identification capability, selectivity, detection limit, reporting limit, carryover, and stability.
  • Instrument maintenance and troubleshooting records relevant to the batch.
  • Aliquot history and documentation of reanalysis or repeated container opening.
  • Chain-of-custody records.
  • Scene photographs and inventories of aerosol products or containers.
  • Emergency medical, resuscitation, hospital, autopsy, and investigative records.

For a general record-review workflow, see Toxicology Data Review and Chain of Custody in Forensic Toxicology.

Frequently asked forensic questions

Does a negative urine drug screen exclude DFE exposure?

No. A routine urine drug screen may not be designed to detect DFE at all. The analytical scope must be identified before a negative result is interpreted.

Can DFE be detected several hours after inhalation?

Potentially yes. Published modeling indicates that blood detectability may persist for hours, but the actual interval depends on exposure, physiology, specimen handling, and the analytical detection limit.

Does a positive DFE blood result prove impairment at the time of a crash?

No. It supports exposure and may be consistent with recent inhalation, but retrospective impairment requires consideration of collection delay, concentration decline, observed behavior, collision evidence, other substances, and the limits of the available pharmacokinetic data.

Can a DFE concentration determine exactly when inhalation occurred?

Not reliably from concentration alone. Rapid distribution and elimination, variable inhalation patterns, body composition, and specimen handling can materially affect the measured concentration.

Should postmortem DFE be interpreted from one blood specimen alone?

Whenever available, interpretation is stronger when peripheral and central blood results are considered with alternative matrices, scene evidence, autopsy findings, and the complete analytical record.

Selected scientific sources

Scientific education only. Case-specific conclusions require review of the complete records, analytical method, specimens, and relevant medical and investigative evidence.